Environmental Stress, Genes and Risk of Hypertension
环境压力、基因和高血压风险
基本信息
- 批准号:7479054
- 负责人:
- 金额:$ 32.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAffectAfrican AmericanAgeAmericanAnimalsAntioxidantsBehavioralBiochemicalBiologicalBiological AssayBiological MarkersBiometryBloodBlood PressureBlood VesselsBlood specimenBody mass indexBudgetsCandidate Disease GeneCardiovascular DiseasesCardiovascular systemCarotid Atherosclerotic DiseaseChildhoodChronicChronic stressComorbidityCorticotropin-Releasing Hormone ReceptorsDahl Hypertensive RatsDevelopmentDiscriminationDiseaseEarly identificationEconomicsEndotheliumEnvironmentEpidemicEssential HypertensionEtiologyEuropeanEvaluationExcretory functionExhibitsExposure toFamilyFastingFigs - dietaryForeheadFreezingFunctional disorderFutureGenesGeneticGenetic Predisposition to DiseaseGenotypeGlucocorticoid ReceptorGlucoseHealthHigh Blood PressureHigh Density Lipoprotein CholesterolHomeostasisHomologous GeneHumanHydrocortisoneHypertensionHypertriglyceridemiaHypothalamic structureIndividualIndividual DifferencesInsulinInsulin ResistanceInterviewInvasiveKidneyLaboratoriesLeft Ventricular MassLifeLightLinkLipidsLongitudinal StudiesManuscriptsMeasurementMeasuresMediatingMetabolicModelingMorbidity - disease rateNervous System PhysiologyNorepinephrineObesityOxidantsOxidative StressOxidative Stress PathwayPathway interactionsPatientsPatternPharmacogeneticsPharmacologic SubstancePhysiologic pulsePhysiologicalPituitary GlandPlasmaPlayPreparationPrevention approachPrincipal InvestigatorProcessPsychosocial StressPulse takingReactive Oxygen SpeciesReceptor GeneRegulationRenin-Angiotensin SystemResearchResearch DesignRestRiskRoleSalivarySamplingSecondary PreventionServicesSlideSodiumSpottingsStressSuperoxide DismutaseSympathetic Nervous SystemSystemTechnologyTestingThickTimeUnited StatesUrineVariantVascular remodelingVentricular RemodelingVideo GamesVisitVitaminsWorkYouthabuse neglectacute stressarterial stiffnessbasebiobehaviorbiological adaptation to stressblood pressure regulationcohortdata managementdesignextracellularfollow-upgene environment interactionhemodynamicshuman CYBA proteinhuman studyimprovedindexingintima medialifestyle interventionmimeticspediatric traumapost gamma-globulinsposterspre-clinicalprogramsreceptorresponsesocialstressorurinary
项目摘要
The objective of Project 2 is to ascertain how chronic environmental stress in combination with unfavorable
genotypes via 2 new mechanistic pathways (hypothalamic-pituitary-adrenocortical [HPA] axis and oxidative
stress) affects BP reactivity to acute stress and development of preclinical cardiovascular disease (CVD).
The Project will study a cohort of 300 African Americans and 307 European Americans (mean age will be
25.5 yrs) who have been evaluated 14 times over a 17-year period. The continued follow-up of this cohort
will allow us to examine the cumulative effects of environmental stress, genotypes and their interaction on
the time course of the development of preclinical measures of CVD over a period of 22 years. Subjects will
have hemodynamic measures and indices of HPA axis and oxidative stress assessed prior to and
immediately following three acute laboratory challenges, as well as in the naturalistic field setting. Subjects
will also have measures of preclinical CVD evaluated. Two key genes in each of the HPA and oxidative
stress pathways will be assessed by a gene-wide approach with all variants within a candidate gene
considered jointly. In context of the recent evidence suggesting that activation of HPA axis and oxidative
stress play an important role in obesity related EH, we hypothesize that obesity will exacerbate the
activation of these two pathways which are elevated by chronic environmental stress. Specific aims of
Project 2 are to test the hypotheses that individuals from chronically stressful environments and/or with
unfavorable genotypes will exhibit greater increases over time in HPA axis and oxidative stress response to
acute stressors and chronic stress (i.e., natural environment assessment) and measures of preclinical CVD.
Possible moderating influences of obesity will also be examined. We will also test the hypotheses that
individuals with higher levels (when originally measured) and/or greater increases over time in HPA and
oxidative stress responses to acute stress will exhibit higher levels of BP reactivity and measures of
preclinical CVD.
The long term objective of Project 2 is to improve the understanding of the way stress contributes to the
development of EH. Findings will contribute to development of behavioral pharmacogenetic therapies which
will include lifestyle interventions and pharmaceutical therapies in which the role of stress is taken into
account. These efforts will result in more efficacious and personalized primary and secondary prevention
approaches of EH and its co-morbidities.
项目 2 的目标是确定长期环境压力与不利因素的结合如何影响
通过 2 条新机制途径(下丘脑-垂体-肾上腺皮质 [HPA] 轴和氧化
压力)影响血压对急性压力的反应以及临床前心血管疾病(CVD)的发展。
该项目将研究 300 名非洲裔美国人和 307 名欧洲裔美国人的队列(平均年龄为
25.5 岁),在 17 年期间接受了 14 次评估。对该队列的持续随访
将使我们能够研究环境压力、基因型及其相互作用的累积影响
22 年期间 CVD 临床前措施开发的时间进程。受试者将
在之前和之前评估了血流动力学指标以及 HPA 轴和氧化应激指数
紧接着三个严峻的实验室挑战以及自然主义现场环境。科目
还将对临床前 CVD 指标进行评估。 HPA 和氧化各有两个关键基因
应激途径将通过全基因范围的方法对候选基因内的所有变异进行评估
共同考虑。最近的证据表明 HPA 轴的激活和氧化
压力在肥胖相关的 EH 中起着重要作用,我们假设肥胖会加剧 EH
这两条途径的激活会因慢性环境压力而升高。具体目标
项目 2 旨在测试来自长期压力环境和/或患有慢性压力环境的个体的假设
不利的基因型将随着时间的推移,HPA 轴和氧化应激反应表现出更大的增加
急性应激源和慢性应激(即自然环境评估)以及临床前 CVD 的测量。
还将研究肥胖可能的调节影响。我们还将检验以下假设:
HPA 水平较高(最初测量时)和/或随时间推移增加幅度较大的个体,
对急性应激的氧化应激反应将表现出更高水平的血压反应性和测量
临床前CVD。
项目 2 的长期目标是提高对压力如何影响健康的理解。
EH的发展。研究结果将有助于行为药物遗传学疗法的发展
将包括生活方式干预和药物治疗,其中考虑了压力的作用
帐户。这些努力将带来更有效和个性化的一级和二级预防
EH 及其合并症的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frank A Treiber其他文献
Frank A Treiber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frank A Treiber', 18)}}的其他基金
Patient Centered Health Technology Medication Adherence Program for African American Hypertensives
以患者为中心的非裔美国人高血压健康技术药物依从计划
- 批准号:
9381307 - 财政年份:2017
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Medication Adherence Stops Hypertension (SMASH) Among Hispanics
坚持使用智能手机药物可阻止西班牙裔高血压 (SMASH)
- 批准号:
8702567 - 财政年份:2014
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Medication Adherence Stops Hypertension (SMASH) Among Hispanics
坚持使用智能手机药物可阻止西班牙裔高血压 (SMASH)
- 批准号:
8822912 - 财政年份:2014
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
- 批准号:
8506076 - 财政年份:2013
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
- 批准号:
8666040 - 财政年份:2013
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
- 批准号:
9298690 - 财政年份:2013
- 资助金额:
$ 32.14万 - 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
- 批准号:
9066182 - 财政年份:2013
- 资助金额:
$ 32.14万 - 项目类别:
Fit Body and Soul: A Lifestyle Intervention for Diabetes Prevention Conducted Thr
身心健康:预防糖尿病的生活方式干预措施
- 批准号:
7560284 - 财政年份:2008
- 资助金额:
$ 32.14万 - 项目类别:
Sociodemographic Regulation of CV Function and Structure
CV功能和结构的社会人口学调节
- 批准号:
7587401 - 财政年份:2007
- 资助金额:
$ 32.14万 - 项目类别:
Sociodemographic Regulation of CV Function and Structure
CV功能和结构的社会人口学调节
- 批准号:
8208579 - 财政年份:2007
- 资助金额:
$ 32.14万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 32.14万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别: